summary
Introduced
01/13/2025
01/13/2025
In Committee
02/13/2025
02/13/2025
Crossed Over
Passed
Dead
Introduced Session
2025-2026 Regular Session
Bill Summary
AN ACT Relating to access to psychedelic substances by 2 individuals 21 years of age or older; amending RCW 7.48.310, 3 69.50.101, 49.60.180, 18.130.010, 18.130.180, and 19.410.020; 4 reenacting and amending RCW 43.79A.040, 43.79A.040, and 18.130.040; 5 adding a new section to chapter 42.56 RCW; adding a new section to 6 chapter 15.130 RCW; adding a new chapter to Title 18 RCW; adding a 7 new chapter to Title 66 RCW; creating new sections; prescribing 8 penalties; providing an effective date; providing expiration dates; 9 and declaring an emergency. 10
AI Summary
This bill establishes a comprehensive regulatory framework for the legal use and administration of psychedelic substances in Washington State, primarily focusing on psilocybin. The bill creates a regulated system for adults 21 and older to access psychedelic substances under controlled, supervised conditions. Key provisions include establishing a licensing system for facilitators and service centers, creating a Washington Psychedelic Substances Board to oversee implementation, and setting strict guidelines for administration sessions. The legislation aims to protect public health by requiring trained facilitators, mandatory preparation and integration sessions, and comprehensive safety protocols. The bill emphasizes equity and accessibility, recognizing potential therapeutic benefits for historically marginalized communities while also being mindful of keeping regulatory costs manageable. Importantly, the bill provides protections for health professionals and clients, ensuring they cannot be penalized for participating in psychedelic substance services that comply with the new regulations. The framework allows for future expansion to include other psychedelic substances beyond psilocybin and sets up mechanisms for ongoing research and data collection to better understand the risks and benefits of psychedelic substances.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (14)
Jesse Salomon (D)*,
Jessica Bateman (D),
Mike Chapman (D),
Noel Frame (D),
Bob Hasegawa (D),
Jeff Holy (R),
Curtis King (R),
Liz Lovelett (D),
T'wina Nobles (D),
Rebecca Saldaña (D),
Mark Schoesler (R),
Yasmin Trudeau (D),
Lisa Wellman (D),
Jeff Wilson (R),
Last Action
By resolution, reintroduced and retained in present status. (on 01/12/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...